$3.29
-0.15-4.36%
At close: -
$3.48
0.195.78%
After Hours: 9:23 AM EDT
Comments
Loading...
Cardiff Oncology Earnings Estimates, EPS & Revenue | NASDAQ:CRDF | Benzinga
Cardiff Oncology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS Estimate
$-0.260
Quarterly Revenue Estimate
$37.50K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$683.00K
Analyze the earnings history of Cardiff Oncology using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRDF | Cardiff Oncology | -$0.22 | -$0.26 | — | — | $205.00K | $37.50K | — | — | 05/01/2025 | Get Alert |
| CRDF | Cardiff Oncology | -$0.21 | -$0.25 | -$0.21 | 16.00% | $156.00K | $94.17K | $151.00K | 60.35% | 02/27/2025 | Get Alert |
| CRDF | Cardiff Oncology | -$0.22 | -$0.27 | -$0.25 | 7.41% | $141.00K | $80.00K | $165.00K | 106.25% | 11/07/2024 | Get Alert |
| CRDF | Cardiff Oncology | -$0.25 | -$0.25 | -$0.26 | -4.00% | $108.00K | $60.00K | $163.00K | 171.67% | 08/08/2024 | Get Alert |
| CRDF | Cardiff Oncology | -$0.25 | -$0.25 | -$0.22 | 12.00% | $83.00K | $50.00K | $205.00K | 310.00% | 05/02/2024 | Get Alert |
| CRDF | Cardiff Oncology | -$0.20 | -$0.28 | -$0.21 | 25.00% | $128.00K | $40.00K | $156.00K | 290.00% | 02/29/2024 | Get Alert |
| CRDF | Cardiff Oncology | -$0.20 | -$0.28 | -$0.22 | 21.43% | $93.00K | $60.00K | $141.00K | 135.00% | 11/02/2023 | Get Alert |
| CRDF | Cardiff Oncology | -$0.24 | -$0.27 | -$0.25 | 7.41% | $91.00K | $40.00K | $108.00K | 170.00% | 08/09/2023 | Get Alert |
| CRDF | Cardiff Oncology | -$0.25 | -$0.23 | -$0.25 | -8.70% | $74.00K | $60.00K | $83.00K | 38.33% | 05/04/2023 | Get Alert |
| CRDF | Cardiff Oncology | -$0.23 | -$0.23 | -$0.20 | 13.04% | $133.00K | $70.00K | $128.00K | 82.86% | 03/02/2023 | Get Alert |
| CRDF | Cardiff Oncology | -$0.17 | -$0.26 | -$0.20 | 23.08% | $86.00K | $70.00K | $93.00K | 32.86% | 11/03/2022 | Get Alert |
| CRDF | Cardiff Oncology | -$0.17 | -$0.27 | -$0.24 | 11.11% | $68.00K | $60.00K | $91.00K | 51.67% | 08/04/2022 | Get Alert |
| CRDF | Cardiff Oncology | -$0.14 | -$0.23 | -$0.25 | -8.70% | $72.00K | $50.00K | $74.00K | 48.00% | 05/05/2022 | Get Alert |
| CRDF | Cardiff Oncology | -$0.19 | -$0.17 | -$0.23 | -35.29% | $119.00K | $40.00K | $133.00K | 232.50% | 02/24/2022 | Get Alert |
| CRDF | Cardiff Oncology | -$0.19 | -$0.17 | -$0.17 | 0.00% | $136.00K | $30.00K | $86.00K | 186.67% | 11/04/2021 | Get Alert |
| CRDF | Cardiff Oncology | -$0.51 | -$0.15 | -$0.17 | -13.33% | $43.00K | $150.00K | $68.00K | -54.67% | 08/05/2021 | Get Alert |
| CRDF | Cardiff Oncology | -$0.41 | -$0.16 | -$0.14 | 12.50% | $68.00K | $160.00K | $72.00K | -55.00% | 05/06/2021 | Get Alert |
| CRDF | Cardiff Oncology | -$0.51 | — | -$0.19 | — | $93.00K | — | $119.00K | — | 02/25/2021 | Get Alert |
| CRDF | Cardiff Oncology | -$0.71 | — | -$0.19 | — | $52.00K | — | $136.00K | — | 11/05/2020 | Get Alert |
| CRDF | Cardiff Oncology | -$0.76 | — | -$0.51 | — | $138.00K | — | $43.00K | — | 08/11/2020 | Get Alert |
| CRDF | Cardiff Oncology | -$1.02 | — | -$0.41 | — | $162.00K | — | $68.00K | — | 05/07/2020 | Get Alert |
Cardiff Oncology (CRDF) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $-0.21 | $-0.25 | 16.0 % |
| Q3 | 2024-11-07 | $-0.25 | $-0.27 | 7.41 % |
| Q2 | 2024-08-08 | $-0.26 | $-0.25 | -4.00 % |
| Q1 | 2024-05-02 | $-0.22 | $-0.25 | 12.0 % |
Cardiff Oncology (CRDF) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $151.00K | $94.17K | 60.4 % |
| Q3 | 2024-11-07 | $165.00K | $80.00K | 106.3 % |
| Q2 | 2024-08-08 | $163.00K | $60.00K | 171.7 % |
| Q1 | 2024-05-02 | $205.00K | $50.00K | 310.0 % |
FAQ
When is Cardiff Oncology (NASDAQ:CRDF) reporting earnings?
Cardiff Oncology (CRDF) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Cardiff Oncology (NASDAQ:CRDF)?
The Actual EPS was $-0.21, which beat the estimate of $-0.25.
What were Cardiff Oncology’s (NASDAQ:CRDF) revenues?
The Actual Revenue was $151K, which beat the estimate of $94.2K.
Browse earnings estimates, EPS, and revenue on all stocks.